LON:SAR Sareum (SAR) Share Price, News & Analysis → Protect Your Bank Account Before It’s Too Late (From Weiss Ratings) (Ad) Free SAR Stock Alerts GBX 41 0.00 (0.00%) (As of 06/7/2024 ET) Add Compare Share Share Today's Range 40▼ 4350-Day Range 10.25▼ 45.2052-Week Range 10▼ 140Volume283,065 shsAverage Volume1.07 million shsMarket Capitalization£44.26 millionP/E RatioN/ADividend Yield1.10%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsHeadlinesInsider TradesStock AnalysisChartCompetitorsHeadlinesInsider Trades Get Sareum alerts: Email Address Ad Weiss RatingsProtect Your Bank Account Before It’s Too LateFor months I’ve been warning about the federal government’s terrifying new program to control every American’s bank account. It gives them the power to monitor every single transaction …Stop right now and do these 3 things to protect yourself About Sareum Stock (LON:SAR)Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor that is in a Phase 1a clinical trials for the treatment of autoimmune diseases. Its also developing SDC-1802, a TYK2/JAK1 inhibitor, which is in preclinical stage for cancerandcancer-immunotherapy applications; and SRA737, a clinical-stage, oral, selective Checkpoint kinase 1 (Chk1) inhibitor, which has completed Phase II clinical trials that targets cancer cell replication and DNA damage repair mechanisms. The company was incorporated in 2004 and is headquartered in Cambridge, the United Kingdom.Read More SAR Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SAR Stock News HeadlinesMay 2, 2024 | msn.comFed meeting, Amazon results, struggling US consumer - what's moving marketsApril 11, 2024 | lse.co.ukIssue of RiverFort Subscription SharesApril 4, 2024 | morningstar.comSareum Holdings PLC SARApril 4, 2024 | uk.investing.comSareum Holdings: A decisive period ahead for SDC-1801April 1, 2024 | msn.comTop 10 War Movies Based on Real Life You Can Watch on NetflixMarch 17, 2024 | lse.co.ukSareum Holdings touts new patent allowance for autoimmune therapyMarch 12, 2024 | lse.co.ukSareum shares slump on widened loss and funding talksFebruary 28, 2024 | finance.yahoo.comSareum Holdings plc (LON:SAR): Are Analysts Optimistic?February 19, 2024 | au.finance.yahoo.comSareum Holdings PLC (RYH0.SG)February 15, 2024 | lse.co.ukSareum hails safety profile for SDC-1801 after phase 1 trialJanuary 2, 2024 | lse.co.ukLONDON MARKET MIDDAY: London stocks make largely soft start to 2024January 2, 2024 | proactiveinvestors.com.auSareum surges as partner agrees licence for promising moleculeJanuary 2, 2024 | lse.co.ukSareum soars as partner agrees SRA737 licence with US biopharma firmDecember 14, 2023 | lse.co.ukEARNINGS AND TRADING: CleanTech raises GBP520,000 in open offerNovember 23, 2023 | fool.co.ukSareum shares just jumped 22%! Here’s whyNovember 9, 2023 | lse.co.ukEARNINGS AND TRADING: MetalNRG hails Gold Ridge findingsNovember 5, 2023 | msn.comThe 25 Best Sad Movies On Netflix That Will Give You All The FeelsNovember 3, 2023 | lse.co.ukSareum says patent notice in Japan boosts confidence in SDC-1801November 3, 2023 | marketwatch.comSareum Holdings Nears Patent for Autoimmune Disease Treatment in JapanOctober 13, 2023 | msn.comFTSE 100 Live: Jeremy Hunt warns on UK economy, Arm dips below IPO price, Next seals FatFace dealOctober 9, 2023 | lse.co.ukLONDON MARKET EARLY CALL: Higher call as high rate narrative settlesOctober 9, 2023 | lse.co.ukSareum says earnings down but product development going wellOctober 6, 2023 | lse.co.ukLONDON MARKET CLOSE: Stocks end higher, shaking off US nonfarms beatSeptember 5, 2023 | msn.comSareum doses first subjects in second stage of Phase 1a trial of SDC-1801September 4, 2023 | lse.co.ukSareum begins dosing participants in phase 1a trial for SDC-1801See More Headlines Receive SAR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sareum and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeLON SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolLON:SAR CUSIPN/A CIKN/A Webwww.sareum.co.uk Phone+44-1223-497700FaxN/AEmployees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX (0.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income£-4,250,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-257.72% Return on Assets-113.80% Debt Debt-to-Equity RatioN/A Current Ratio3.93 Quick Ratio10.37 Sales & Book Value Annual Sales£47,204.00 Price / Sales937.62 Cash FlowGBX 3.62 per share Price / Cash Flow11.32 Book ValueGBX 1 per share Price / Book41.00Miscellaneous Outstanding Shares107,950,000Free FloatN/AMarket Cap£44.26 million OptionableNot Optionable Beta-1.03 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesDr. Timothy John Mitchell Ph.D. (Age 64)Founder, CEO & Executive Director Comp: $207.85kDr. John Charles Reader Ph.D. (Age 57)Founder, Chief Scientific Officer & Executive Director Comp: $205.8kMr. Clive H. W. Birch F.C.A. (Age 70)Senior Independent Non-Executive Director & Secretary Comp: $25kAlexandra HarrisonHead of IRKey CompetitorsAvacta GroupLON:AVCTCircassia GroupLON:CIRFutura MedicalLON:FUMTiziana Life SciencesLON:TILSVerseonLON:VSNView All CompetitorsInsidersJohn C ReaderSold 50,426 sharesTotal: £2.87 M ($57.00/share)Clive BirchBought 2,479 shares on 9/4/2023Total: £203,278.00 ($82.00/share)View All Insider Transactions SAR Stock Analysis - Frequently Asked Questions How have SAR shares performed in 2024? Sareum's stock was trading at GBX 59.50 on January 1st, 2024. Since then, SAR shares have decreased by 31.1% and is now trading at GBX 41. View the best growth stocks for 2024 here. What other stocks do shareholders of Sareum own? Based on aggregate information from My MarketBeat watchlists, some companies that other Sareum investors own include ReNeuron Group (RENE), ValiRx (VAL), Sierra Oncology (SRRA), Egdon Resources (EDR), Collagen Solutions plc (COS.L) (COS), Gulf Keystone Petroleum (GKP), Madagascar Oil (MOIL), Summit Therapeutics (SMMT), Rockhopper Exploration (RKH) and How do I buy shares of Sareum? Shares of SAR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.Compare Top Brokerages Here. This page (LON:SAR) was last updated on 6/9/2024 by MarketBeat.com Staff From Our PartnersCollapse of the Petrodollar The death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredRSVP: Charles Payne’s Cash Flow WorkshopDid you know you could "cash flow" the stocks in your portfolio? Without selling a single share of stock? ...Unstoppable Prosperity | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sareum Holdings plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Sareum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
